In about one-third of patients with hereditary retinoblastoma, the first mutation has been transmitted from an affected parent. In this situation, sibs and offspring have a genetic recurrence risk of 50%. In the other patients with hereditary retinoblastoma, a new mutation has occurred spontaneously in a
Retinoblastoma (Rb) belongs to a group of childhood tumours predisposition to which can be inherited as an autosomal dominant trait. ' The gene locus has been assigned to the long arm of human chromosome 13, region 1, band 4.2 Two genetic events are assumed to be required to initiate tumour formation.3
In hereditary retinoblastoma (40% of cases), the patients carry a germinal mutation at one of the two homologous Rb loci in all their cells. Retinoblastoma develops from a retinoblast that has lost the wild type allele on the homologous chromosome, either by mitotic non-disjunction, mitotic crossing over, gene conversion, deletion, or point mutation during the development of the retina.4 Mitotic non-disjunction and crossing over occur in approximately 50% of tumours and lead to hemior homozygosity for all or part of chromosome 13. 5 Patients with hereditary retinoblastoma usually have bilateral or multifocal unilateral retinoblastoma. However, a small number of these patients develop only one tumour or do not have tumour development at all.
In about one-third of patients with hereditary retinoblastoma, the first mutation has been transmitted from an affected parent. In this situation, sibs and offspring have a genetic recurrence risk of 50%. In the other patients with hereditary retinoblastoma, a new mutation has occurred spontaneously in a Received for publication 29 September 1987. Accepted for publication 5 November 1987. parental germ cell. In these families offspring, but not sibs, of the patient are at increased risk.
In about 60% of all retinoblastoma patients tumour formation results from two independent somatic mutations in the same retinoblast. This is non-hereditary retinoblastoma, which is always unifocal and unilateral, and neither sibs nor offspring are at an increased risk.
Unfortunately Family ES-0083 was informative for the marker G14E1.9 and the mutation was unlikely to be present in the subject II.3 at a confidence level of about 90%. Up to the age of one year the child has not developed any signs of a retinoblastoma.
Discussion
Using cloned DNA probes linked to the retinoblastoma gene locus on chromosome 13, we have been able to offer predictive genetic tests to six families with hereditary predisposition to this disease. In most cases the confidence level was close to that of direct gene diagnosis, which we have recently performed in three other families. 16 Although probes and techniques are now being develoCped for detecting point mutations within a gene,2 21 most mutations at the Rb locus cannot at present be detected directly. Furthermore, owing to a high mutation ratel and negative selection, the mutations are expected to be heterogeneous. In contrast to many haemoglobin mutants, heterogeneity will make it difficult to apply the same approach in many families. Thus, linkage analysis will remain useful in many families despite its drawbacks, such as the need for a full family analysis and the risk of recombination between the marker and the retinoblastoma locus. The latter problem, however, will be overcome as more intragenic RFLPs are being identified.
In the families studied here, a minimum of two subjects were affected by the disease. Indirect DNA diagnosis can also be performed in families with only one affected member provided the patient has bilateral or multifocal unilateral retinoblastoma (that is, carries a germinal mutation) and has at least one child that has passed the age of onset (usually two to three years of age). However 
